ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ENVB Enveric Biosciences Inc

0.90
-0.034 (-3.64%)
Apr 25 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 88,601
Bid Price 0.89
Ask Price 0.935
News -
Day High 0.9583

Low
0.649

52 Week Range

High
6.98

Day Low 0.88
Company Name Stock Ticker Symbol Market Type
Enveric Biosciences Inc ENVB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.034 -3.64% 0.90 19:47:02
Open Price Low Price High Price Close Price Prev Close
0.94 0.88 0.9583 0.90 0.934
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
205 88,601 $ 0.9130393 $ 80,896 - 0.649 - 6.98
Last Trade Time Type Quantity Stock Price Currency
18:25:32 1 $ 0.8975 USD

Enveric Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.09M 2.32M - 0 -17.46M -7.52 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Enveric Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ENVB Message Board. Create One! See More Posts on ENVB Message Board See More Message Board Posts

Historical ENVB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.940.980.85580.9045893117,183-0.04-4.26%
1 Month1.021.190.831.01257,778-0.12-11.76%
3 Months0.71972.920.6491.374,713,0970.180325.05%
6 Months1.892.920.6491.362,221,016-0.99-52.38%
1 Year1.606.980.6492.552,010,518-0.70-43.75%
3 Years2.3514.870.15512.011,687,345-1.45-61.70%
5 Years6.0014.870.15512.612,069,811-5.10-85.00%

Enveric Biosciences Description

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Your Recent History

Delayed Upgrade Clock